Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Cardiovascular magnetic resonance imaging pattern in patients with autoimmune rheumatic diseases and ventricular tachycardia with preserved ejection fraction.

Mavrogeni SI, Sfikakis PP, Markousis-Mavrogenis G, Bournia VK, Poulos G, Koutsogeorgopoulou L, Karabela G, Stavropoulos E, Katsifis G, Boki K, Vartela V, Kolovou G, Theodorakis G, Kitas GD.

Int J Cardiol. 2019 Jun 1;284:105-109. doi: 10.1016/j.ijcard.2018.10.067. Epub 2018 Oct 25.

PMID:
30404725
2.

Combined brain and heart magnetic resonance imaging in systemic vasculitides: fiction or real need?

Mavrogeni S, Kitas GD, Lamb HJ, Psychogios K, Dimitroulas T, Koutsogeorgopoulou L, Boki K, Vartela V, Kolovou G, Markousis-Mavrogenis G, Kallenberg CG, Guillevin L, Vassilopoulos D.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):152-159. Epub 2018 Apr 10. Review.

3.

Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug Persistence.

Flouri ID, Markatseli TE, Boki KA, Papadopoulos I, Skopouli FN, Voulgari PV, Settas L, Zisopoulos D, Iliopoulos A, Geborek P, Drosos AA, Boumpas DT, Sidiropoulos P.

J Rheumatol. 2018 Jun;45(6):785-794. doi: 10.3899/jrheum.170477. Epub 2018 Apr 1.

4.

Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.

Fanouriakis A, Adamichou C, Koutsoviti S, Panopoulos S, Staveri C, Klagou A, Tsalapaki C, Pantazi L, Konsta S, Mavragani CP, Dimopoulou D, Ntali S, Katsikas G, Boki KA, Vassilopoulos D, Konstantopoulou P, Liossis SN, Elezoglou A, Tektonidou M, Sidiropoulos P, Erden A, Sfikakis PP, Bertsias G, Boumpas DT.

Semin Arthritis Rheum. 2018 Dec;48(3):467-474. doi: 10.1016/j.semarthrit.2018.02.014. Epub 2018 Feb 23.

PMID:
29555348
5.

Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases.

Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Dimitroulas T, Bratis K, Kitas GD, Sfikakis P, Tektonidou M, Karabela G, Stavropoulos E, Katsifis G, Boki KA, Kitsiou A, Filaditaki V, Gialafos E, Plastiras S, Vartela V, Kolovou G.

Int J Cardiol. 2017 Jun 1;236:151-156. doi: 10.1016/j.ijcard.2017.01.104. Epub 2017 Feb 1.

PMID:
28185705
6.

Treatment with the first TNF inhibitor in rheumatoid arthritis patients in the Hellenic Registry of Biologic Therapies improves quality of life especially in young patients with better baseline functional status.

Boubouchairopoulou N, Flouri I, Drosos AA, Boki K, Settas L, Zisopoulos D, Skopouli FN, Papadopoulos I, Iliopoulos A, Kyriopoulos J, Boumpas DT, Athanasakis K, Sidiropoulos P.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):999-1005. Epub 2016 Oct 7.

PMID:
27749220
7.

Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life study.

Vassilopoulos D, Delicha EM, Settas L, Andrianakos A, Aslanidis S, Boura P, Katsounaros M, Athanassiou P, Tempos K, Skarantavos G, Antoniadis C, Papazoglou S, Sakkas L, Galanopoulou V, Skopouli F, Boki K, Daoussis D, Vritzali E, Sfikakis PP.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5):893-900. Epub 2016 Jul 5.

8.

Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases.

Papanikolaou IC, Boki KA, Giamarellos-Bourboulis EJ, Kotsaki A, Kagouridis K, Karagiannidis N, Polychronopoulos VS.

Immunol Lett. 2015 Feb;163(2):179-86. doi: 10.1016/j.imlet.2014.12.004. Epub 2014 Dec 23.

PMID:
25540922
9.

Chronic periaortitis (retroperitoneal fibrosis) concurrent with giant cell arteritis: a case report.

Protopsaltis I, Sotiropoulos A, Foteinos A, Manoloudaki K, Boki K, Linardaki G, Papazafiropoulou A, Antonopoulos S.

J Med Case Rep. 2014 May 27;8:167. doi: 10.1186/1752-1947-8-167.

10.

Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival.

Flouri I, Markatseli TE, Voulgari PV, Boki KA, Papadopoulos I, Settas L, Zisopoulos D, Skopouli FN, Iliopoulos A, Bertsias GK, Geborek P, Drosos AA, Boumpas DT, Sidiropoulos P.

Semin Arthritis Rheum. 2014 Feb;43(4):447-57. doi: 10.1016/j.semarthrit.2013.07.011. Epub 2013 Sep 6.

PMID:
24012040
11.

Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis.

Tzelepis GE, Kokosi M, Tzioufas A, Toya SP, Boki KA, Zormpala A, Moutsopoulos HM.

Eur Respir J. 2010 Jul;36(1):116-21. doi: 10.1183/09031936.00110109. Epub 2009 Nov 19.

12.

Intravenous immunoglobulin treatment for pregnancy-associated dermatomyositis.

Linardaki G, Cherouvim E, Goni G, Boki KA.

Rheumatol Int. 2011 Jan;31(1):113-5. doi: 10.1007/s00296-009-1166-2. Epub 2009 Oct 21.

PMID:
19844719
13.

Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusion.

Rudwaleit M, Olivieri I, Boki KA, Griep EN, Järvinen P, Wong RL, Kron M, Kary S, Kupper H.

Rheumatology (Oxford). 2009 May;48(5):551-7. doi: 10.1093/rheumatology/kep022. Epub 2009 Mar 1.

PMID:
19254918
14.

Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis.

Moyssakis I, Gialafos E, Vassiliou VA, Boki K, Votteas V, Sfikakis PP, Tzelepis GE.

Scand J Rheumatol. 2009 May-Jun;38(3):216-21. doi: 10.1080/03009740802474672.

PMID:
19229673
15.

Evidence-based recommendations for the management of ankylosing spondylitis: results of the Hellenic working group of the 3E Initiative in Rheumatology.

Raptopoulou A, Sidiropoulos P, Siakka P, Boki K, Drosos AA, Aslanidis S, Karras D, Pikazis D, Vassilopoulos D, Karassa F, Boumpas DT; Hellenic working group of the 3E Initiative in Rheumatology.

Clin Exp Rheumatol. 2008 Sep-Oct;26(5):784-92.

PMID:
19032809
16.

Thoracoabdominal motion in ankylosing spondylitis: association with standardised clinical measures and response to therapy.

Tzelepis GE, Kalliakosta G, Tzioufas AG, Sfikakis PP, Mandros C, Boki KA, Roussos C, Moutsopoulos HM.

Ann Rheum Dis. 2009 Jun;68(6):966-71. doi: 10.1136/ard.2008.092650. Epub 2008 Jul 16.

PMID:
18633126
17.

Is the heart affected in primary Sjögren's syndrome? An echocardiographic study.

Vassiliou VA, Moyssakis I, Boki KA, Moutsopoulos HM.

Clin Exp Rheumatol. 2008 Jan-Feb;26(1):109-12.

PMID:
18328155
18.

High speed and reproducible analysis of nitrosamines by capillary electrophoresis with a sulfonated capillary.

Taga A, Nishi T, Honda Y, Sato A, Terashima H, Suzuki K, Kodama S, Boki K.

J Oleo Sci. 2007;56(8):429-34.

19.

Acute hepatitis following mycophenolate mofetil administration for ANCA-positive vasculitis.

Dourakis SP, Boki K, Soultati A, Cherouvim E, Delladetsima I.

Scand J Rheumatol. 2007 May-Jun;36(3):237-9. No abstract available.

PMID:
17657683
20.

Chest CT findings in patients with inflammatory myopathy and Jo1 antibodies.

Karadimitrakis S, Plastiras SC, Zormpala A, Chatzikonstantinou K, Boki KA, Tzelepis GE, Moutsopoulos HM.

Eur J Radiol. 2008 Apr;66(1):27-30. Epub 2007 Jul 2.

PMID:
17604929
21.

Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection.

Linardaki G, Katsarou O, Ioannidou P, Karafoulidou A, Boki K.

J Rheumatol. 2007 Jun;34(6):1353-5.

PMID:
17552060
22.

Infliximab Therapy for Patients With Active and Refractory Spondyloarthropathies at the Dose of 3 mg/kg: A 20-Month Open Treatment.

Cherouvim EP, Zintzaras E, Boki KA, Moutsopoulos HM, Manoussakis MN.

J Clin Rheumatol. 2004 Aug;10(4):162-8.

PMID:
17043505
23.

Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project".

Cervera R, Abarca-Costalago M, Abramovicz D, Allegri F, Annunziata P, Aydintug AO, Bacarelli MR, Bellisai F, Bernardino I, Biernat-Kaluza E, Blockmans D, Boki K, Bracci L, Campanella V, Camps MT, Carcassi C, Cattaneo R, Cauli A, Cervera R, Chwalinska-Sadowska H, Contu L, Cosyns JP, Danieli MG, DCruz D, Depresseux G, Direskeneli H, Domènech I, Espinosa G, Fernández-Nebro A, Ferrara GB, Font J, Frutos MA, Galeazzi M, Garcìa-Carrasco M, García Iglesias MF, García-Tobaruela A, George J, Gil A, González-Santos P, Grana M, Gül A, Haga HJ, de Haro-Liger M, Houssiau F, Hughes GR, Ingelmo M, Jedryka-Góral A, Khamashta MA, Lavilla P, Levi Y, López-Dulpa M, López-Soto A, Maldykowa H, Marcolongo R, Mathieu A, Morozzi G, Nicolopoulou N, Papasteriades C, Passiu G, Perelló I, Petera P, Petrovic R, Piette JC, Pintado V, de Pita O, Popovic R, Pucci G, Puddu P, de Ramón E, Ramos-Casals M, Rodríguez-Andreu J, Ruiz-Irastorza G, Sanchez-Lora J, Sanna G, Scorza R, Sebastiani GD, Sherer Y, Shoenfeld Y, Simpatico A, Sinico RA, Smolen J, Tincani A, Tokgöz G, Urbano-Márquez A, Vasconcelos C, Vázquez JJ, Veronesi J, Vianna J, Vivancos J; European Working Party on Systemic Lupus Erythematosus.

Autoimmun Rev. 2006 Mar;5(3):180-6. Epub 2005 Jul 26. Review.

PMID:
16483917
24.

Uptake of heterocyclic aromatic amine by insoluble dietary fiber in artificial gastric and intestinal juice.

Iuchi A, Nakahori Y, Boki K.

Environ Health Prev Med. 2004 Mar;9(2):47-52. doi: 10.1007/BF02897931.

25.

Lupus nephritis: treatment with mycophenolate mofetil.

Kapitsinou PP, Boletis JN, Skopouli FN, Boki KA, Moutsopoulos HM.

Rheumatology (Oxford). 2004 Mar;43(3):377-80. Epub 2004 Jan 6.

PMID:
14963204
26.

Hemoptysis as the first symptom of limited cutaneous systemic sclerosis.

Pasalidou E, Tzavara V, Vondetsianos Ch, Boki K.

Clin Exp Rheumatol. 2003 Jan-Feb;21(1):140. No abstract available.

PMID:
12673910
27.

Lessons from the "Euro-Lupus Cohort".

Cervera R, Abarca-Costalago M, Abramovicz D, Allegri F, Annunziata P, Aydintug AO, Bacarelli MR, Bellisai F, Bernardino I, Biernat-Kaluza E, Blockmans D, Boki K, Bracci L, Campanella V, Camps MT, Carcassi C, Cattaneo R, Cauli A, Chwalinska-Sadowska H, Contu L, Cosyns JP, Danieli MG, D'Cruz D, Depresseux G, Direskeneli H, Domènech I, Espinosa G, Fernández-Nebro A, Ferrara GB, Font J, Frutos MA, Galeazzi M, García-Carrasco M, García-Iglesias MF, García-Tobaruela A, George J, Gil A, González-Santos P, Grana M, Gül A, Haga HJ, de Haro-Liger M, Houssiau F, Hughes GR, Ingelmo M, Jedryka-Góral A, Khamashta MA, Lavilla P, Levi Y, López-Dupla M, López-Soto A, Maldykowa H, Marcolongo R, Mathieu A, Morozzi G, Nicolopoulou N, Papasteriades C, Passiu G, Perelló I, Petera P, Petrovic R, Piette JC, Pintado V, de Pita O, Popovic R, Pucci G, Puddu P, de Ramón E, Ramos-Casals M, Rodríguez-Andreu J, Ruiz-Irastroza G, Sánchez-Lora J, Sanna G, Scorza R, Sebastini GD, Sherer Y, Shoenfeld Y, Simpatico A, Sinico RA, Smolen J, Tincani A, Tokgöz G, Urbano-Márquez A, Vasconcelos C, Vázquez JJ, Veronesi M, Vianni J, Vivancos J; European Working Party on Systemic Lupus Erythematosus.

Ann Med Interne (Paris). 2002 Dec;153(8):530-6.

PMID:
12610427
28.

Shared epitopes and rheumatoid arthritis: disease associations in Greece and meta-analysis of Mediterranean European populations.

Ioannidis JP, Tarassi K, Papadopoulos IA, Voulgari PV, Boki KA, Papasteriades CA, Drosos AA.

Semin Arthritis Rheum. 2002 Jun;31(6):361-70.

PMID:
12077708
29.

How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.

Boki KA, Ioannidis JP, Segas JV, Maragkoudakis PV, Petrou D, Adamopoulos GK, Moutsopoulos HM.

J Rheumatol. 2001 Apr;28(4):798-801.

PMID:
11327253
30.

Genetic polymorphism of IL-12 p40 gene in immune-mediated disease.

Hall MA, McGlinn E, Coakley G, Fisher SA, Boki K, Middleton D, Kaklamani E, Moutsopoulos H, Loughran TP Jr, Ollier WE, Panayi GS, Lanchbury JS.

Genes Immun. 2000 Feb;1(3):219-24.

31.

Hypertrophic cardiomyopathy in systemic lupus erythematosus.

Anastasiadis GP, Moyssakis I, Boki K, Kyriakidis M.

Mayo Clin Proc. 2001 Jan;76(1):111. No abstract available.

PMID:
11155404
32.

Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome.

Tektonidou MG, Ioannidis JP, Moyssakis I, Boki KA, Vassiliou V, Vlachoyiannopoulos PG, Kyriakidis MK, Moutsopoulos HM.

Ann Rheum Dis. 2001 Jan;60(1):43-8.

33.

Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus.

Karassa FB, Ioannidis JP, Boki KA, Touloumi G, Argyropoulou MI, Strigaris KA, Moutsopoulos HM.

Am J Med. 2000 Dec 1;109(8):628-34.

PMID:
11099682
34.

Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome.

Tektonidou MG, Ioannidis JP, Boki KA, Vlachoyiannopoulos PG, Moutsopoulos HM.

QJM. 2000 Aug;93(8):523-30.

PMID:
10924534
35.

Takayasu's arteritis-associated aneurysm formation without steno-occlusive lesions.

Boki KA, Pakas J, Kekatou K, Kataxaki E, Papapavlou E.

Clin Rheumatol. 2000;19(3):226-8.

PMID:
10870660
36.

Risk factors for central nervous system involvement in systemic lupus erythematosus.

Karassa FB, Ioannidis JP, Touloumi G, Boki KA, Moutsopoulos HM.

QJM. 2000 Mar;93(3):169-74.

PMID:
10751236
37.
38.

Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide.

Ioannidis JP, Boki KA, Katsorida ME, Drosos AA, Skopouli FN, Boletis JN, Moutsopoulos HM.

Kidney Int. 2000 Jan;57(1):258-64.

39.

Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis.

Boletis JN, Ioannidis JP, Boki KA, Moutsopoulos HM.

Lancet. 1999 Aug 14;354(9178):569-70.

PMID:
10470708
40.

Pure red cell aplasia as presentation of systemic lupus erythematosus: antibodies to erythropoietin.

Linardaki GD, Boki KA, Fertakis A, Tzioufas AG.

Scand J Rheumatol. 1999;28(3):189-91.

PMID:
10380844
41.

Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis.

Vaiopoulos G, Boki K, Kapsimali V, Coulocheri S, Papadaki HA, Eliopoulos GD.

Haematologia (Budap). 1998;29(2):89-99.

PMID:
9728801
42.

HLA-TNF haplotype heterogeneity in Greek SLE patients.

Tarassi K, Carthy D, Papasteriades C, Boki K, Nikolopoulou N, Carcassi C, Ollier WE, Hajeer AH.

Clin Exp Rheumatol. 1998 Jan-Feb;16(1):66-8.

PMID:
9543565
43.

Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients.

Boki KA, Dafni U, Karpouzas GA, Papasteriades C, Drosos AA, Moutsopoulos HM.

Br J Rheumatol. 1997 Oct;36(10):1059-66.

PMID:
9374922
44.

Mannose-binding lectin gene polymorphism in Greek systemic lupus erythematosus patients.

Carthy D, Hajeer A, Ollier B, Tarassi K, Papasteriades C, Boki K, Nikolopoulou N.

Br J Rheumatol. 1997 Nov;36(11):1238-9. No abstract available.

PMID:
9402880
45.

Facial heliotrope rash as the initial manifestation of acute myelomonocytic leukemia.

Tzavara V, Stamoulis K, Aroni KG, Kordossis T, Boki KA.

Leuk Lymphoma. 1997 Apr;25(3-4):393-8.

PMID:
9168450
46.

Mixed cryoglobulinemia in Greece. Primary disorders in 10 cases.

Boki KA, Linardaki GD, Galanopoulou V, Vaiopoulos G, Tzioufas AG, Moutsopoulos HM.

Scand J Rheumatol. 1997;26(4):280-6.

PMID:
9310108
47.

HLA phenotypes in healthy aged subjects.

Papasteriades C, Boki K, Pappa H, Aedonopoulos S, Papasteriadis E, Economidou J.

Gerontology. 1997;43(3):176-81.

PMID:
9142512
48.

Thrombotic thrombocytopenic purpura in adult Still's disease.

Boki KA, Tsirantonaki MJ, Markakis K, Moutsopoulos HM.

J Rheumatol. 1996 Feb;23(2):385-7.

PMID:
8882053
49.

Giant cell arteritis presenting as pulseless disease of the upper extremities.

Hatzis GS, Aroni KG, Kelekis DA, Boki KA.

Clin Rheumatol. 1996 Jan;15(1):88-90.

PMID:
8929786
50.

Prevalence of antikeratin antibodies in Greek patients with rheumatoid arthritis. A clinical, serologic, and immunogenetic study.

Boki KA, Kurki P, Holthofer H, Tzioufas AG, Drosos AA, Moutsopoulos HM.

J Rheumatol. 1995 Nov;22(11):2046-8.

PMID:
8596142

Supplemental Content

Support Center